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Abstract:  Hypovitaminosis  D  is  associated  with  cognitive  decline  in  the  elderly,  but  the  issue  of  causality  remains 
unresolved. Definitive evidence would include the visualization of brain lesions resulting from hypovitaminosis D. The 
aim of the present article is to determine, through a literature review, the location and nature of possible brain disorders in 
hypovitaminosis  D.  We  found  limited  brain-imaging  data,  which  reported  ischemic  infarcts  and  white  matter 
hyperintensities in hypovitaminosis D, though did not provide their specific location or report any focal atrophy. Based on 
the finding of executive dysfunctions (i.e., mental shifting and information updating impairments) in the presence of 
hypovitaminosis D, we suggest that hypovitaminosis D is associated with a dysfunction of the frontal-subcortical neuronal 
circuits, particularly the dorsolateral circuit. Further imaging studies are required to corroborate this assumption and to 
determine whether hypovitaminosis D results in degenerative and / or vascular lesions. 
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INTRODUCTION 
  Vitamin D is  a secosteroid hormone and its deficiency 
has  been  associated  with  a  variety  of  systemic  diseases 
including  brain  dysfunction  [1-10].  In  particular,  research 
studies during the past five years have repeatedly shown an 
association between hypovitaminosis D and both global and 
domain-specific declines in cognitive performance [4]. The 
strength  of  these  associations  is  yet  limited  by  the  cross-
sectional design of the studies, which prevents determining 
whether dementia precipitates hypovitaminosis D or whether 
hypovitaminosis D has a role in precipitating cognitive dec-
line  and  dementia.  Definitive  evidence  to  infer  causality 
would be to visualize an impact of hypovitaminosis D on the 
brain, for example to highlight some brain variation specifi-
cally  related  to  hypovitaminosis  D.  In  particular,  several 
brain structures may be affected by low levels of vitamin D 
since  this  neurosteroid  hormone  has  been  experimentally 
shown to have anti-neurodegenerative as well as anti-ische-
mic effects, by binding to the neuronal Vitamin D Receptors 
(VDR) [1-3]. Determining which part of the brain varies in 
the  presence  of  hypovitaminosis  D,  and  by  which  mecha-
nism, therefore seems crucial. We wished to underline in this 
manuscript new prospects in the understanding of vitamin D 
action in the brain. In particular, our aim was to determine 
from the literature the location and nature of possible brain 
lesions in older adults with hypovitaminosis D. 
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METHODS 
  In general, the location of a brain lesion can be investi-
gated in two ways: either it can be located by paraclinical 
techniques,  including  morphological  and  functional  brain 
imaging or electroencephalography; or it is the result of a 
clinical reflection based on the interpretation of the neuro-
logical signs, which are usually closely linked to the strategic 
location of the damage. To be as comprehensive as possible, 
we  examined  all  references  to  vitamin  D  in  the  brain-
imaging and clinical literatures. 
RESULTS 
  First, we found that the literature of brain imaging has 
yielded  only  one  study  on  this  specific  issue  [5].  In  this 
study,  the  authors  did  not  find  a  significant  association 
between vitamin D status and hippocampal volume among a 
cohort of 318 older community-dwelling subjects (mean age 
73.5±8.1 years, 72.6% women). However, it was found that 
ischemic  infarcts  (16.1%  versus  6.9%,  P<0.01)  and  white 
matter hyperintensities (higher volume: 4.9 versus 2.9 mL, 
P=0.004;  and  higher  grade:  3.2  versus  2.2,  P=0.02)  were 
associated  with  hypovitaminosis  D  [5].  Nevertheless,  this 
study did not specify the location of the vascular lesions and 
did not seek other focal atrophies. 
  Second, the analysis of the literature on clinical signs of 
hypovitaminosis D helped to identify brain areas of interest. 
More precisely, previous studies found significant associa-
tions  between  serum  25-hydroxyvitamin  D  concentrations 
(25OHD)  and  scores  on  domain-specific  cognitive  tests 
assessing executive functions. Executive functions refer to a 
heterogeneous  set  of  high-level  processes  that  control  and Vitamin D and Brain Imaging  The Open Neuroimaging Journal, 2012, Volume 6     17 
regulate other abilities and behaviours [11]. More precisely, 
executive functions can be grouped into three specific areas: 
mental shifting (i.e., the ability to move from one cognitive 
operation to another), cognitive inhibition (i.e., the ability to 
inhibit  an  automatic  response),  and  information  updating 
(i.e., updating information in working memory) [11]. Each 
subdomain of  executive functions can be  tested separately 
with  specific  psychometric  measures,  and  a  possible  link 
between  vitamin  D  level  and  each  sub-test  score  can  be 
explored. In particular, Buell et al., [7] found among 1,080 
older  adults  (75  years;  76%  female)  that  serum  25OHD 
concentration  was  associated  with  better  mental  shifting 
performance illustrated by lower score on the part B of the 
Trail  Making  Test  (TMT  B)  (β=  -0.73  with  P=0.02)  after 
adjustment  for  age,  gender,  body  mass  index,  education 
level,  kidney  function,  level  of  physical  activity,  alcohol 
consumption, center and season tested. A longitudinal cohort 
study by Llewellyn et al., [8] confirmed the link between 
vitamin D and mental shifting by showing among 858 adults 
aged 65 and older, followed over 6 years, the relative risk for 
significant decline in TMT B score was 1.31 [95% CI: 1.03-
1.51]  among  subjects  initially  deficient  in  vitamin  D 
compared to those with a normal vitamin D status, even after 
adjustment for age, gender, education level, initial TMT B 
score, alcohol and tobacco consumption, depression, energy 
intake,  rate  of  vitamin  E,  degree  of  mobility  and  season 
tested. Parallel, an association was also found between low 
levels  of  vitamin  D  and  impaired  updating  performance 
assessed with a task of spatial working memory [9]. In this 
study,  the  authors  examined  387  European  aged  55  to  87 
years  (49.4%  female).  The  results  showed  that  the  serum 
25OHD concentration was inversely correlated with the total 
number  of  errors  in  the  task  (r=  -0.174,  P<0.003)  [8].  In 
addition, subjects belonging to the highest tertile of 25OHD 
made fewer errors than those in the lowest tertile of 25OHD 
(P=0.04) [8]. Finally, Jorde et al., [10] explored the associa-
tion between vitamin D  and cognitive  inhibition using the 
Stroop  test  in  148  adults  aged  62  years  on  average  (46% 
female). In this study, the authors failed to find a significant 
association  between  serum  25OHD  concentrations  and  the 
Stroop test score Parts 1 and 2 (β=0.12 with t=1.05) or Part 3 
(β= -0.07 t= -0.68) after  adjustment for age, gender, body 
mass  index,  education  level,  health  status  and  serum 
parathyroid hormone concentration [9]. 
DISCUSSION 
  The identification of the impact of hypovitaminosis D on 
the brain through the use of imaging techniques has received 
little  attention  to  date.  The  limited  available  data  reported 
more ischemic infarcts and white matter hyperintensities in 
the presence of hypovitaminosis D, but did not provide the 
location  of  these  vascular  lesions  and  reported  no  focal 
atrophies. In contrast, a growing body of neuropsychological 
research  has  demonstrated  impairments  in  executive  func-
tions, particularly in mental shifting and information update-
ing, among adults with hypovitaminosis D [7-10]. Since the 
expression of a neurological injury is directly related to its 
location,  the  detailed  analysis  of  the  neuropsychological 
signs observed in hypovitaminosis D should help to identify 
brain areas of interest to evaluate in future studies. 
  Anatomically,  executive  functions  are  primarily  under-
pinned  by  the  frontal  lobes,  but  subcortical  structures  are 
also involved. At the cortical level, the prefrontal cortex is 
the structure devoted to executive functions and is the only 
cortical region capable of integrating memory and motiva-
tional,  emotional  and  somatosensory  information  towards 
achieving a single action [12-14]. At the subcortical level, 
the caudate nucleus, the putamen, the pallidum, the nucleus 
accumbens  and  the  thalamus  are  connected  to  the  frontal 
cortex by three main frontal-subcortical neuronal circuits: the 
dorsolateral,  orbitofrontal  and  anterior  cingulate  circuits. 
Because of the brain structures specifically involved in these 
circuits, each circuit is responsible for specific subdomains 
of executive functions [12-19]. In particular, the dorsolateral 
circuit - which is supplied by the middle cerebral artery - is 
involved in the selection of goal, planning, mental shifting, 
information  updating,  working  memory,  visual  spatial 
memory and self-activation [12,14-16], while the orbitofron-
tal circuit, vascularized by anterior and middle cerebral arte-
ries, is involved in social behavior and cognitive inhibition 
[12,17,18]. Finally, the anterior cingulate circuit - supplied 
by the anterior cerebral artery - is involved in error correc-
tion,  behavior  monitoring  and  cognitive  inhibition  [12,14, 
19].  Any  lesion  in  these  frontal-subcortical  circuits,  inde-
pendent of its  level (i.e.  cortical or sub-cortical) or nature 
(i.e.,  atrophy  or  vascular),  may  result  in  domain-specific 
executive  dysfunctions  [12-19].  As  a  consequence,  the 
finding of executive dysfunctions primarily characterized by 
impairements of mental shifting and information updating in 
hypovitaminosis  D  [7-10]  makes  us  suggest  that  hypo-
vitaminosis D could be associated with a dysfunction of the 
frontal-subcortical neuronal circuits, particularly the dorso-
lateral circuit. Underlying lesions would be either degenera-
tive with cortical and / or subcortical atrophies in the circuit, 
or  ischemia  that  would  preferentially  affect  the  vascular 
territory  of  the  middle  cerebral  artery.  Further  imaging 
studies are therefore needed to corroborate these hypotheses, 
to determine whether the dorsolateral circuit is specifically 
altered  in  the  case  of  hypovitaminosis  D,  and  whether 
hypovitaminosis  D  may  contribute  to  degenerative  or 
vascular lesions. 
  Such a finding would help to better understand the invol-
vement of vitamin D in the course of dementia, and would 
also provide an additional rationale for prescribing vitamin D 
supplementation among adults with hypovitaminosis D. 
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